- Home
- RLAY vs NML Comparison
RLAY vs NML Comparison
Compare RLAY & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- NML
- Stock Information
- Founded
- RLAY 2015
- NML 2012
- Country
- RLAY United States
- NML United States
- Employees
- RLAY N/A
- NML N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- NML Finance/Investors Services
- Sector
- RLAY Health Care
- NML Finance
- Exchange
- RLAY Nasdaq
- NML Nasdaq
- Market Cap
- RLAY 490.3M
- NML 454.4M
- IPO Year
- RLAY 2020
- NML N/A
- Fundamental
- Price
- RLAY $3.15
- NML $8.57
- Analyst Decision
- RLAY Strong Buy
- NML
- Analyst Count
- RLAY 11
- NML 0
- Target Price
- RLAY $18.40
- NML N/A
- AVG Volume (30 Days)
- RLAY 2.2M
- NML 219.3K
- Earning Date
- RLAY 05-05-2025
- NML 01-01-0001
- Dividend Yield
- RLAY N/A
- NML 9.75%
- EPS Growth
- RLAY N/A
- NML N/A
- EPS
- RLAY N/A
- NML N/A
- Revenue
- RLAY $7,679,000.00
- NML N/A
- Revenue This Year
- RLAY N/A
- NML N/A
- Revenue Next Year
- RLAY $169.23
- NML N/A
- P/E Ratio
- RLAY N/A
- NML N/A
- Revenue Growth
- RLAY N/A
- NML N/A
- 52 Week Low
- RLAY $1.78
- NML $6.09
- 52 Week High
- RLAY $10.72
- NML $7.33
- Technical
- Relative Strength Index (RSI)
- RLAY 50.08
- NML 49.10
- Support Level
- RLAY $2.75
- NML $8.31
- Resistance Level
- RLAY $3.10
- NML $8.63
- Average True Range (ATR)
- RLAY 0.20
- NML 0.15
- MACD
- RLAY 0.01
- NML -0.01
- Stochastic Oscillator
- RLAY 58.16
- NML 27.69
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.